Literature DB >> 35673581

Aptamers used for molecular imaging and theranostics - recent developments.

Lennart Bohrmann1,2, Tobias Burghardt1, Charles Haynes3, Katayoun Saatchi1, Urs O Häfeli1,2.   

Abstract

Aptamers are single stranded oligonucleotides that fold into three dimensional structures and are able to recognize a variety of molecular targets. Due to the similarity to antibodies with regards to specificity and affinity and their chemical versatility, aptamers are increasingly used to create targeted probes for in vivo molecular imaging and therapy. Hence, aptamer-based probes have been utilized in practically all major imaging modalities such as nuclear imaging, magnetic resonance imaging, x-ray computed tomography, echography and fluorescence imaging, as well as newer modalities such as surface enhanced Raman spectroscopy. Aside from targeting, aptamers have been used for the creation of sensors that allow the localized detection of cellular markers such as ATP in vivo. This review focuses on in vivo studies of aptamer-based probes for imaging and theranostics since the comprehensive overview by Bouvier-Müller and Ducongé in 2018. © The author(s).

Entities:  

Keywords:  in vivo imaging; Aptamers; drug delivery; molecular imaging; nanomedicine

Mesh:

Substances:

Year:  2022        PMID: 35673581      PMCID: PMC9169359          DOI: 10.7150/thno.72949

Source DB:  PubMed          Journal:  Theranostics        ISSN: 1838-7640            Impact factor:   11.600


  17 in total

1.  Where are all the aptamers?

Authors:  Geoffrey S Baird
Journal:  Am J Clin Pathol       Date:  2010-10       Impact factor: 2.493

2.  Near Infrared-Guided Smart Nanocarriers for MicroRNA-Controlled Release of Doxorubicin/siRNA with Intracellular ATP as Fuel.

Authors:  Penghui Zhang; Chen Wang; Jingjing Zhao; Anqi Xiao; Qi Shen; Linting Li; Jianxin Li; Junfeng Zhang; Qianhao Min; Jiangning Chen; Hong-Yuan Chen; Jun-Jie Zhu
Journal:  ACS Nano       Date:  2016-02-26       Impact factor: 15.881

Review 3.  Aptamers and the RNA world, past and present.

Authors:  Larry Gold; Nebojsa Janjic; Thale Jarvis; Dan Schneider; Jeffrey J Walker; Sheri K Wilcox; Dom Zichi
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

4.  Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases.

Authors:  Peter K Kaiser
Journal:  Am J Ophthalmol       Date:  2006-10       Impact factor: 5.258

5.  Cell-surface sensors for real-time probing of cellular environments.

Authors:  Weian Zhao; Sebastian Schafer; Jonghoon Choi; Yvonne J Yamanaka; Maria L Lombardi; Suman Bose; Alicia L Carlson; Joseph A Phillips; Weisuong Teo; Ilia A Droujinine; Cheryl H Cui; Rakesh K Jain; Jan Lammerding; J Christopher Love; Charles P Lin; Debanjan Sarkar; Rohit Karnik; Jeffrey M Karp
Journal:  Nat Nanotechnol       Date:  2011-07-17       Impact factor: 39.213

Review 6.  Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.

Authors:  Mark J Ernsting; Mami Murakami; Aniruddha Roy; Shyh-Dar Li
Journal:  J Control Release       Date:  2013-09-25       Impact factor: 9.776

Review 7.  Translation of aptamers toward clinical diagnosis and commercialization.

Authors:  Shan Liu; Yixin Xu; Xin Jiang; Hong Tan; Binwu Ying
Journal:  Biosens Bioelectron       Date:  2022-03-16       Impact factor: 10.618

8.  Dual-triggered oxygen self-supply black phosphorus nanosystem for enhanced photodynamic therapy.

Authors:  Jintong Liu; Ping Du; Hui Mao; Lei Zhang; Huangxian Ju; Jianping Lei
Journal:  Biomaterials       Date:  2018-04-26       Impact factor: 12.479

9.  Cell-specific aptamer probes for membrane protein elucidation in cancer cells.

Authors:  Dihua Shangguan; Zehui Cao; Ling Meng; Prabodhika Mallikaratchy; Kwame Sefah; Hui Wang; Ying Li; Weihong Tan
Journal:  J Proteome Res       Date:  2008-03-26       Impact factor: 4.466

Review 10.  Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?

Authors:  Mayte Sola; Ashwathi Puravankara Menon; Beatriz Moreno; Daniel Meraviglia-Crivelli; Mario Martínez Soldevilla; Fernando Cartón-García; Fernando Pastor
Journal:  Mol Ther Nucleic Acids       Date:  2020-05-23       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.